Akeso Inc

STU:4RY (China)   Ordinary Shares
€ 7.45 (-0.67%) Dec 20
At Loss
P/B:
9.23
Market Cap:
€ 6.64B ($ 6.92B)
Enterprise V:
€ 6.67B ($ 6.96B)
Volume:
600.00
Avg Vol (2M):
600.00
Trade In:

Business Description

Description
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in Mainland China.
Name Current Vs Industry Vs History
Cash-To-Debt 0.9
Equity-to-Asset 0.5
Debt-to-Equity 0.64
Debt-to-EBITDA -6.1
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.85
Distress
Grey
Safe
Beneish M-Score 0.99
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Book Growth Rate 8.3
Name Current Vs Industry Vs History
5-Day RSI 35.33
9-Day RSI 37.83
14-Day RSI 41.12
6-1 Month Momentum % 101.46
12-1 Month Momentum % 64.36

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.79
Quick Ratio 4.43
Cash Ratio 2.11
Days Inventory 1045.81
Days Sales Outstanding 65.48
Days Payable 908.19

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.2
Shareholder Yield % -3.96

Financials (Next Earnings Date:2025-02-28 Est.)

STU:4RY's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Akeso Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 240.31
EPS (TTM) (€) -0.112
Beta 0.37
Volatility % 57.47
14-Day RSI 41.12
14-Day ATR (€) 0.225101
20-Day SMA (€) 8.15
12-1 Month Momentum % 64.36
52-Week Range (€) 3.66 - 9.35
Shares Outstanding (Mil) 897.56

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Akeso Inc Filings

Filing Date Document Date Form
No Filing Data

Akeso Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Akeso Inc Frequently Asked Questions

What is Akeso Inc(STU:4RY)'s stock price today?
The current price of STU:4RY is €7.45. The 52 week high of STU:4RY is €9.35 and 52 week low is €3.66.
When is next earnings date of Akeso Inc(STU:4RY)?
The next earnings date of Akeso Inc(STU:4RY) is 2025-02-28 Est..
Does Akeso Inc(STU:4RY) pay dividends? If so, how much?
Akeso Inc(STU:4RY) does not pay dividend.

Press Release

Subject Date
No Press Release